Trials / Completed
CompletedNCT06413810
The Effects of a Food Ingredient on Self-reported Stress
A Randomised, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of a Food Ingredient on Self-reported Stress in Healthy Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Unilever R&D · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to investigate if a food ingredient can improve stress in healthy adults who experience moderate symptoms of self-reported stress. The main question it aims to answer is if 4 weeks of daily intake of the ingredient reduces stress compared to 4 weeks of daily intake of a placebo product. Participants will: * consume both the test and placebo products for 4-weeks each in a randomised order, with 4 weeks in between * visit the test site 6 times over the 13 weeks * complete a series of assessments on stress and sleep quality and provide blood, stool and saliva samples
Detailed description
A double-blind, randomised, placebo-controlled, crossover study with 6 visits over 13-weeks. Participants will consume study product or placebo for two 4-week intervention periods. Primary Objective: To evaluate in healthy adults, experiencing moderate symptoms of self-reported stress, the effect of 4-week daily supplementation of a food ingredient versus placebo on stress. Secondary Objectives: To evaluate in healthy adults, experiencing moderate symptoms of self-reported stress, the effect of 4-week daily supplementation of a food ingredient versus placebo on: * Mood * Plasma GABA levels * Salivary cortisol awakening response (CAR) * Acute effects on stress * Faecal GABA
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Calmarell | Food ingredient |
| OTHER | Placebo | Blinded placebo |
Timeline
- Start date
- 2024-07-15
- Primary completion
- 2024-11-22
- Completion
- 2024-11-22
- First posted
- 2024-05-14
- Last updated
- 2025-01-13
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT06413810. Inclusion in this directory is not an endorsement.